Structural analysis of human growth hormone with respect to the dominant expression of growth hormone (GH) mutations in isolated GH deficiency type II

Endocrinology

Volumn 146, Issue 3, 2005, Pages 1411-1417

  Iliev, Daniel I ^a   Wittekindt, Nicola E ^a   Ranke, Michael B ^a   Binder, Gerhard ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; BETA GALACTOSIDASE; CYSTEINE; DISULFIDE; GROWTH HORMONE; LUCIFERASE; SOMATOMEDIN BINDING PROTEIN 2;

ALPHA HELIX; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPRESSION VECTOR; GENE DELETION; GENE DISRUPTION; GENETIC TRANSFECTION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HETEROZYGOSITY; HORMONE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; WILD TYPE;

BETA-GALACTOSIDASE; BINDING SITES; BLOTTING, WESTERN; CYSTEINE; DISULFIDES; DNA; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE DELETION; GENES, DOMINANT; HETEROZYGOTE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; LUCIFERASES; MUTATION; PLASMIDS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RADIOIMMUNOASSAY; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TRANSFECTION;

EID: 14244257227     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0868     Document Type: Article

References (21)

1. Phillips JA, Cogan JD 1994 Genetic basis of endocrine disease. VI. Molecular basis of familial human growth hormone deficiency. J Clin Endocrinol Metab 78:11-16
2. Phillips III JA, Hjelle BL, Seeburg PH, Zachmann M 1981 Molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci USA 78:6372-6375
3. Akinci A, Kanaka C, Eble A, Akar N, Vidinlisan S, Mullis PE 1992 Isolated growth hormone (GH) deficiency type IA associated with a 45-kilobase gene deletion within the human GH gene cluster. J Clin Endocrinol Metab 75:437-441
4. Procter AM, Phillips JA, Cooper DN 1998 The molecular genetics of growth hormone deficiency. Hum Genet 103:255-272
5. Baumann G, Maheshwari H 1997 The dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. Acta Paediatr 423(Suppl):33-38
6. Binder G, Ranke MB 1995 Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 80:1247-1252
7. Cogan JD, Phillips JA, Schenkman SS, Milner RD, Sakati N 1994 Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein. J Clin Endocrinol Metab 79:1261-1265
8. Ultsch MH, Somers W, Kossiakoff AA, de Vos AM 1994 The crystal structure of affinity-matured human growth hormone at 2 A resolution. J Mol Biol 236:286-299
9. Baumann G 1991 Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 12:424-449
10. Binder G, Brown M, Parks JS 1996 Mechanisms responsible for dominant expression of human growth hormone gene mutations. J Clin Endocrinol Metab 81:4047-4050
11. Hayashi Y, Yamamoto M, Ohmori S, Kamijo T, Ogawa M, Seo H 1999 Inhibition of growth hormone (GH) secretion by a mutant GH-1 gene product in neuroendocrine cells containing secretory granules: an implication for isolated GH deficiency inherited in an autosomal dominant manner. J Clin Endocrinol Metab 84:2134-2139
12. Lee MS, Wajnrajch MP, Kim SS, Plotnick IP, Wang J, Gertner JM, Leibel RL, Dannies PS 2000 Autosomal dominant growth hormone (GH) deficiency type II: the del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology 141:883-890
13. Dannies PS 2000 Protein folding and deficiencies caused by dominant-negative mutants of hormones. Vitam Horm 58:1-26
14. Graves TK, Patel S, Dannies PS, Hinkle PM 2001 Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic. J Cell Sci 114:3685-3694
15. McGuinness L, Magoulas C, Sesay AK, Mathers K, Carmignac D, Manneville JB, Christian H, Phillips III JA, Robinson IC 2003 Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology 144:720-731
16. Binder G, Nagel BH, Ranke MB, Mullis PE 2002 Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin. Eur J Endocrinol 147:755-760
17. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR 1989 Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59
18. Hauffa BP, Lehmann N, Bettendorf M, Mehls O, Dorr HG, Partsch CJ, Schwarz HP, Stahnke N, Steinkamp H, Said E, Sander S, Ranke MB 2004 Central reassessment of GH concentrations measured at local treatment centers in children with impaired growth: consequences for patient management. Eur J Endocrinol 150:291-297
19. Elmlinger MW, Wimmer K, Biemer E, Blum WF, Ranke MB Dannecker GE 1996 Insulin-like growth factor binding protein 2 is differentially expressed in leukaemic B- and T-cell lines. Growth Regul 6:152-157
20. Cunningham BC, Mulkerrin MG, Wells JA 1991 Dimerization of human growth hormone by zinc. Science 253:545-548
21. Kauffman KJ, Pridgen EM, Doyle III FJ, Dhurjati PS, Robinson AS 2002 Decreased protein expression and intermittent recoveries in BiP levels result from cellular stress during heterologous protein expression in Saccharomyces cerevisiae. Biotechnol Prog 18:942-950